Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-24-000835
Filing Date
2024-06-04
Accepted
2024-06-04 16:19:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 6840
  Complete submission text file 0001972362-24-000835.txt   8275
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Subject) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-33137 | Film No.: 241018339
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 400 PROFESSIONAL DRIVE SUITE 400 GAITHERSBURG MD 20879
Business Address
Zoon Kathryn C (Reporting) CIK: 0001685720 (see all company filings)

Type: 144